ID
46161
Description
Principal Investigator: Arul Chinnaiyan, M.D., Ph.D, University of Michigan MeSH: prostate cancer https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000443 Noncoding RNAs (ncRNAs) are emerging as key molecules in human cancer, with the potential to serve as novel markers of disease and to reveal uncharacterized aspects of tumor biology. Here we discover 121 unannotated prostate cancer-associated ncRNA transcripts (PCATs) by *ab initio* assembly of high-throughput sequencing of polyA+ RNA (RNA-Seq) from a cohort of 102 prostate tissues and cells lines. We characterized one ncRNA, PCAT-1, as a prostate-specific regulator of cell proliferation and show that it is a target of the polycomb repressive complex 2 (PRC2). We further found that patterns of PCAT-1 and PRC2 expression stratified patient tissues into molecular subtypes distinguished by expression signatures of PCAT-1-repressed target genes. Taken together, our findings suggest that PCAT-1 is a transcriptional repressor implicated in a subset of prostate cancer patients. These findings establish the utility of RNA-Seq to identify disease-associated ncRNAs that may improve the stratification of cancer subtypes.
Lien
Mots-clés
Versions (4)
- 22/07/2022 22/07/2022 - Chiara Middel
- 25/07/2022 25/07/2022 - Martin Dugas
- 12/10/2022 12/10/2022 - Adrian Schulz
- 29/01/2025 29/01/2025 - Akane Nishihara
Détendeur de droits
Arul Chinnaiyan, M.D., Ph.D, University of Michigan
Téléchargé le
29 janvier 2025
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
dbGaP phs000443 Molecular Profiling of Cancer
Sample ID, subject ID, sample sources, and sample use variables associated with participants affected with prostate cancer and involved in the "Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression" project.
- StudyEvent: dbGaP phs000443 Molecular Profiling of Cancer
- Subject ID, consent group, and sources of subjects affected with prostate cancer and involved in the "Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression" project.
- Sample ID, subject ID, sample sources, and sample use variables associated with participants affected with prostate cancer and involved in the "Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression" project.
- Subject ID and gender of participants affected with prostate cancer and involved in the "Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression" project.
- Sample ID, analyte type , body site where from samples were collected, tumor status, and histological type of samples obtained from participants affected with prostate cancer and involved in the "Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression" project.
Similar models
Sample ID, subject ID, sample sources, and sample use variables associated with participants affected with prostate cancer and involved in the "Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression" project.
- StudyEvent: dbGaP phs000443 Molecular Profiling of Cancer
- Subject ID, consent group, and sources of subjects affected with prostate cancer and involved in the "Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression" project.
- Sample ID, subject ID, sample sources, and sample use variables associated with participants affected with prostate cancer and involved in the "Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression" project.
- Subject ID and gender of participants affected with prostate cancer and involved in the "Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression" project.
- Sample ID, analyte type , body site where from samples were collected, tumor status, and histological type of samples obtained from participants affected with prostate cancer and involved in the "Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression" project.
C3847505 (UMLS CUI [1,2])
C0449416 (UMLS CUI [1,2])
C3847505 (UMLS CUI [1,3])
C2347026 (UMLS CUI [1,2])